US Stock MarketDetailed Quotes

Whitehawk Therapeutics (WHWK)

Watchlist
  • 4.930
  • +1.010+25.77%
Close May 13 16:00 ET
  • 4.870
  • -0.060-1.22%
Pre 05:02 ET
243.80MMarket Cap-1.99P/E (TTM)

Whitehawk Therapeutics (WHWK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
-72.50%7.15M
0
0
0
33.48%7.15M
6.69%25.98M
14.43%7.24M
21.03%7.21M
-0.37%6.18M
Operating revenue
--0
-72.50%7.15M
--0
--0
--0
33.48%7.15M
6.69%25.98M
14.43%7.24M
21.03%7.21M
-0.37%6.18M
Cost of revenue
0
-74.87%760K
0
0
0
16.56%760K
7.65%3.02M
-14.78%790K
15.35%804K
18.60%778K
Gross profit
0
-72.19%6.39M
0
0
0
35.82%6.39M
6.56%22.96M
19.45%6.45M
21.78%6.41M
-2.61%5.4M
Operating expense
8.88%23.52M
37.60%120.79M
-2.01%24.89M
13.75%19.55M
160.90%54.75M
-10.78%21.6M
-6.10%87.78M
9.89%25.4M
-25.65%17.18M
-16.36%20.99M
Selling and administrative expenses
-50.92%6.29M
-18.85%29.82M
-46.92%5.87M
-27.62%5.2M
-24.73%5.94M
20.67%12.82M
-17.51%36.75M
6.82%11.05M
-35.96%7.19M
-32.98%7.89M
Research and development costs
96.09%17.23M
78.25%90.96M
32.58%19.02M
43.49%14.35M
272.79%48.81M
-35.35%8.79M
4.29%51.03M
12.37%14.35M
-15.92%10M
-1.67%13.09M
Operating profit
-54.57%-23.52M
-76.49%-114.4M
-31.34%-24.89M
-81.40%-19.55M
-251.32%-54.75M
22.01%-15.22M
9.89%-64.82M
-6.97%-18.95M
39.63%-10.78M
20.27%-15.58M
Net non-operating interest income expense
67.89%1.33M
65.23%6.23M
138.31%1.61M
113.13%1.85M
97.31%1.98M
-35.38%791K
-38.87%3.77M
-53.15%676K
-43.89%868K
-36.40%1M
Non-operating interest income
67.89%1.33M
58.75%6.23M
138.31%1.61M
104.19%1.85M
86.52%1.98M
-38.30%791K
-38.67%3.93M
-54.93%676K
-43.55%906K
-35.11%1.06M
Non-operating interest expense
----
--0
--0
--0
--0
--0
-33.33%154K
--0
-34.48%38K
0.00%58K
Other net income (expense)
3,414.65%87.57M
25K
98.11%-50K
7,850.00%155K
8,744,400.00%87.44M
-264,100.00%-2.64M
0
-2.64M
33.33%-2K
Gain on sale of security
----
225.00%5K
--8K
----
-50.00%-3K
----
-300.00%-4K
--0
---1K
33.33%-2K
Special income (charges)
--0
3,408.04%87.27M
--0
93.29%-177K
--0
--87.44M
---2.64M
--0
---2.64M
--0
-Less:Restructuring and merger&acquisition
----
--0
--0
--0
----
----
--2.64M
--0
--2.64M
----
-Gain on sale of business
--0
--87.27M
--0
---177K
--0
--87.44M
--0
--0
--0
--0
Other non- operating income (expenses)
----
--302K
--17K
--127K
--158K
----
----
----
----
----
Income before tax
-130.40%-22.19M
67.66%-20.6M
-27.24%-23.25M
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
Income tax
0
0
0
0
Net income
-130.40%-22.19M
67.66%-20.6M
-27.24%-23.25M
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
Net income continuous Operations
-130.40%-22.19M
67.66%-20.6M
-27.24%-23.25M
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
Minority interest income
Net income attributable to the parent company
-130.40%-22.19M
67.66%-20.6M
-27.24%-23.25M
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-130.40%-22.19M
67.66%-20.6M
-27.24%-23.25M
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
Basic earnings per share
-117.39%-0.32
86.02%-0.33
49.25%-0.34
43.48%-0.26
-40.74%-0.76
370.59%1.84
3.28%-2.36
-11.67%-0.67
23.33%-0.46
19.40%-0.54
Diluted earnings per share
-117.49%-0.32
86.02%-0.33
49.25%-0.34
43.48%-0.26
-40.74%-0.76
369.12%1.83
3.28%-2.36
-11.67%-0.67
23.33%-0.46
19.40%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0-72.50%7.15M00033.48%7.15M6.69%25.98M14.43%7.24M21.03%7.21M-0.37%6.18M
Operating revenue --0-72.50%7.15M--0--0--033.48%7.15M6.69%25.98M14.43%7.24M21.03%7.21M-0.37%6.18M
Cost of revenue 0-74.87%760K00016.56%760K7.65%3.02M-14.78%790K15.35%804K18.60%778K
Gross profit 0-72.19%6.39M00035.82%6.39M6.56%22.96M19.45%6.45M21.78%6.41M-2.61%5.4M
Operating expense 8.88%23.52M37.60%120.79M-2.01%24.89M13.75%19.55M160.90%54.75M-10.78%21.6M-6.10%87.78M9.89%25.4M-25.65%17.18M-16.36%20.99M
Selling and administrative expenses -50.92%6.29M-18.85%29.82M-46.92%5.87M-27.62%5.2M-24.73%5.94M20.67%12.82M-17.51%36.75M6.82%11.05M-35.96%7.19M-32.98%7.89M
Research and development costs 96.09%17.23M78.25%90.96M32.58%19.02M43.49%14.35M272.79%48.81M-35.35%8.79M4.29%51.03M12.37%14.35M-15.92%10M-1.67%13.09M
Operating profit -54.57%-23.52M-76.49%-114.4M-31.34%-24.89M-81.40%-19.55M-251.32%-54.75M22.01%-15.22M9.89%-64.82M-6.97%-18.95M39.63%-10.78M20.27%-15.58M
Net non-operating interest income expense 67.89%1.33M65.23%6.23M138.31%1.61M113.13%1.85M97.31%1.98M-35.38%791K-38.87%3.77M-53.15%676K-43.89%868K-36.40%1M
Non-operating interest income 67.89%1.33M58.75%6.23M138.31%1.61M104.19%1.85M86.52%1.98M-38.30%791K-38.67%3.93M-54.93%676K-43.55%906K-35.11%1.06M
Non-operating interest expense ------0--0--0--0--0-33.33%154K--0-34.48%38K0.00%58K
Other net income (expense) 3,414.65%87.57M25K98.11%-50K7,850.00%155K8,744,400.00%87.44M-264,100.00%-2.64M0-2.64M33.33%-2K
Gain on sale of security ----225.00%5K--8K-----50.00%-3K-----300.00%-4K--0---1K33.33%-2K
Special income (charges) --03,408.04%87.27M--093.29%-177K--0--87.44M---2.64M--0---2.64M--0
-Less:Restructuring and merger&acquisition ------0--0--0----------2.64M--0--2.64M----
-Gain on sale of business --0--87.27M--0---177K--0--87.44M--0--0--0--0
Other non- operating income (expenses) ------302K--17K--127K--158K--------------------
Income before tax -130.40%-22.19M67.66%-20.6M-27.24%-23.25M-41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M
Income tax 0000
Net income -130.40%-22.19M67.66%-20.6M-27.24%-23.25M-41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M
Net income continuous Operations -130.40%-22.19M67.66%-20.6M-27.24%-23.25M-41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M
Minority interest income
Net income attributable to the parent company -130.40%-22.19M67.66%-20.6M-27.24%-23.25M-41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -130.40%-22.19M67.66%-20.6M-27.24%-23.25M-41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M
Basic earnings per share -117.39%-0.3286.02%-0.3349.25%-0.3443.48%-0.26-40.74%-0.76370.59%1.843.28%-2.36-11.67%-0.6723.33%-0.4619.40%-0.54
Diluted earnings per share -117.49%-0.3286.02%-0.3349.25%-0.3443.48%-0.26-40.74%-0.76369.12%1.833.28%-2.36-11.67%-0.6723.33%-0.4619.40%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More